2018
DOI: 10.1002/jcsm.12298
|View full text |Cite
|
Sign up to set email alerts
|

More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 30 publications
(29 reference statements)
0
5
0
Order By: Relevance
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscores the continuing need for such a niche journal and its two daughter journals, JCSM Rapid Communication and JCSM Clinical Reports. 13 This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased. Nevertheless, there still remains a great unmet medical need, because cachexia and sarcopenia are still associated with an unacceptably high burden of morbidity and mortality affecting patients, families, care-givers, and healthcare systems, and no new therapies exist yet.…”
mentioning
confidence: 99%
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscores the continuing need for such a niche journal and its two daughter journals, JCSM Rapid Communication and JCSM Clinical Reports. 13 This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased. Nevertheless, there still remains a great unmet medical need, because cachexia and sarcopenia are still associated with an unacceptably high burden of morbidity and mortality affecting patients, families, care-givers, and healthcare systems, and no new therapies exist yet.…”
mentioning
confidence: 99%
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscore the continuing need for such a niche journal and its daughter journal, JCSM Rapid Communication 13 . This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased.…”
mentioning
confidence: 94%
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscore the continuing need for such a niche journal and its daughter journal, JCSM Rapid Communication. 13 This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased. Nevertheless, there still remains a great unmet medical need, because cachexia and sarcopenia are still associated with an unacceptably high burden of morbidity and mortality affecting patients, families, care-givers and healthcare systems, and no new therapies exist yet.…”
mentioning
confidence: 99%
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscores the continuing need for such a niche journal and its two daughter journals, JCSM Rapid Communication and JCSM Clinical Reports . This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased.…”
mentioning
confidence: 96%
“…We will continue our editorial work for the JCSM journal family, and the increasing number of submissions underscores the continuing need for such a niche journal and its two daughter journals, JCSM Rapid Communication and JCSM Clinical Reports. 12 This is particularly so, because diagnostic tools have improved and overall awareness and research in cachexia and sarcopenia have increased. Nevertheless, there still remains a great unmet medical need, because cachexia and sarcopenia are still associated with an unacceptably high burden of morbidity and mortality affecting patients, families, caregivers, and healthcare systems and no new therapies exist yet.…”
mentioning
confidence: 99%